Restart Life Sciences Announces Holy Crap's Amazon U.S. Rollout Alongside Next-Generation Protein and Sampling Innovations
Vancouver, British Columbia--(Newsfile Corp. - September 1, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that its premium functional food brand, Holy Crap Foods Inc. ("Holy Crap"), has officially launched in the U.S. market through the Amazon USA platform. The initial U.S. rollout features two of the brand's top-performing super seed SKUs alongside a popular variety package. Following a strong ini
2026-09-01 6:00 AM EDT | Restart Life Sciences Corp.
Numinus Wellness Inc. Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - September 1, 2026) - Numinus Wellness Inc. (OTC Pink: NUMIF) ("Numinus" or the "Company") a mental health care company focused on innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, today announced that it has filed all quarterly interim financial reports for fiscal year 2026 to May 31, 2026. With the re
2026-09-01 5:39 AM EDT | Numinus Wellness Inc.
Altrova Health Reports Third Quarter Fiscal 2026 Financial Results
Toronto, Ontario--(Newsfile Corp. - August 31, 2026) - Altrova Health Inc. (CSE: ROVA) (OTCQB: ATVHF) (FSE: WF8) ("Altrova Health" or the "Company") today announced its financial results for the three and nine-month periods ended June 30, 2026 ("Q3 Fiscal 2026"). The Company's condensed interim consolidated financial statements and related management's discussion and analysis for the period (collectively, the "Interim Filings") have been filed under the Company's p
2026-08-31 6:37 PM EDT | Altrova Health Inc.
Rhelion Life Sciences Reports First Quarter 2027 Results
Toronto, Ontario--(Newsfile Corp. - August 31, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX0) (OTCQB: TRUFF) ("Rhelion" or the "Company"), an Ontario-based organization advancing innovation and research within the legal psychedelic sector, is pleased to report its financial and operational results for the three months ended June 30, 2026 ("Q1 2027"), capping a transitional quarter which culminated in the acquisition of Filament Health Corp. ("Filament"). All figures are reported
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-08-31 8:39 AM EDT | Rhelion Life Sciences Corp.
BetterLife Pharma Appoints Charles Duncan as Director and Chair of the Audit Committee
Vancouver, British Columbia--(Newsfile Corp. - August 31, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company"), an emerging biotechnology company developing BETR-001 for the treatment of migraine and headache disorders, is pleased to announce the appointment of Charles Duncan, PhD as Director and Chair of the Audit Committee. Dr. Duncan is a biotechnology strategist, board director and former top-ranked Wall Street biotechnology anal
2026-08-31 8:00 AM EDT | BetterLife Pharma Inc.
From Full Sail to Full-Scale: Adia Med Inc. Assembles Intern Social Media Team
Winter Park, Florida--(Newsfile Corp. - August 31, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine company focused on stem cell therapies, biologics, and advanced clinical services, today announced that its introductory innovation session earlier this month at Full Sail University delivered exactly the spark the Company was looking for — and that Adia Med has already assembled a social media team of interns to convert that momentum into a new era of organic marketing.
Healthcare and Hospitals, Health
2026-08-31 8:00 AM EDT | Adia Med Inc.
Cheelcare Announces Fourth Quarter and Fiscal 2026 Financial Results and Provides Curio Update
Markham, Ontario--(Newsfile Corp. - August 31, 2026) - Cheelcare Inc. (TSXV: CHER) (OTC: CHCRF) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, today announced its financial results for the fourth quarter and fiscal year ended April 30, 2026. All figures are in CAD unless otherwise noted. Operational Highlights (Year Ended April 30, 2026) Continued revenue and Companion sales growth: Fiscal 2026 revenue increased 22% year-ove
2026-08-31 7:30 AM EDT | Cheelcare Inc.
DiagnosTear Technologies Inc. Announces Private Placement of Units
Vancouver, British Columbia--(Newsfile Corp. - August 31, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company") is pleased to announce it will be proceeding with a non-brokered private placement of up to 2,800,000 units ("Units") at a price of C$0.50 per Unit for aggregate gross proceeds of up to C$1,400,000 (the "Offering"). The Company expects BioLight Life Sciences Ltd., parent company of DiagnosTear, and Elcam Medic
2026-08-31 7:00 AM EDT | DiagnosTear Technologies Inc.
Defence Therapeutics Expands Radiopharmaceutical Development Strategy with Alpha and Beta-Emitter Programs
Montreal, Quebec--(Newsfile Corp. - August 31, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology company developing next-generation precision oncology therapeutics using its proprietary Accum® technology, is pleased to announce the expansion of its radiopharmaceutical development program to evaluate alpha-emitting and beta-emitting radioisotopes. This expansion is to broaden the capabi
Biotechnology, Pharmaceuticals, Health
2026-08-31 3:15 AM EDT | Defence Therapeutics Inc.
Numinus Wellness Inc. Announces Fourth Quarter Fiscal 2025 Results and Provides Corporate Update
Q4 Fiscal 2025 Highlights Revenue of $2.3 million, a 29.0% increase over Q3 2025 Gross profit of $1.4 million, compared to a gross profit of $0.8 million in Q3 2025 Cash position of $0.5 million as of August 31, 2025 Subsequent to Quarter End On April 18, 2026, President Donald Trump signed an executive order directing U.S. federal agencies to accelerate research, acce
2026-08-28 5:00 PM EDT | Numinus Wellness Inc.
BetterLife Pharma Inc. Announces Pricing of US$100 Million Public Offering of Common Shares and Pre-Funded Warrants
Vancouver, British Columbia--(Newsfile Corp. - August 28, 2026) - BetterLife Pharma Inc. (CSE: BETR) ("BetterLife" or the "Company"), a biotechnology company developing treatments for neurological disorders, is pleased to announce today that it has priced its previously announced public offering (the "Offering") of common shares of the Company ("Commo
2026-08-28 8:00 AM EDT | BetterLife Pharma Inc.
NuGen Announces Filing of Corrective Disclosure Pursuant to OSC Review
Toronto, Ontario--(Newsfile Corp. - August 27, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") announces that further to the review by the Ontario Securities Commission ("OSC") of the Company's continuous disclosure, the Company has made corrective disclosure with respect to the following: the Company has included in its recently filed management information circular dated August 17, 2026 (the "Circul
Healthcare and Hospitals, Pharmaceuticals, Health
2026-08-27 5:30 PM EDT | NuGen Medical Devices Inc.
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Issued New United States Patent, Extending the Broadest Natural Psilocybin Patent Estate
Toronto, Ontario--(Newsfile Corp. - August 27, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX0) (OTCQB: TRUFF) ("Rhelion" or the "Company") an Ontario-based organization advancing inno
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-08-27 8:24 AM EDT | Rhelion Life Sciences Corp.
Black Health & Social Services Hub to Celebrate Grand Opening with Community Health, Culture and Wellness Celebration in Brampton
Brampton, Ontario--(Newsfile Corp. - August 27, 2026) - The Black Health and Social Services (BHSS) Hub Peel will officially celebrate its grand opening on Friday, August 28 inviting residents from across Peel Region to experience a new approach to culturally responsive healthcare, mental health, addictions and social services designed with Black, African and Caribbean communities at the centre. Located at 19 Rutherford Road South, Unit 2, Brampton, the BHSS Hub is a partn
Healthcare and Hospitals, Health
2026-08-27 8:00 AM EDT | Black Health & Social Services Hub Peel
Glow Lifetech Reports Positive Q2 2026 Results; Revenue Growth Continues for 12th Consecutive Quarter
Toronto, Ontario--(Newsfile Corp. - August 25, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to report its financial results for the second quarter ended June 30, 2026 ("Q2 2026"). In Q2 2026, Glow delivered continued revenue growth, sustained high gross margins, generated positive cash flow from operations, improved operating efficiency, and completed the elimination of its remaining warrant overhang. These results reflec
2026-08-25 7:30 AM EDT | Glow Lifetech Corp.
Rhelion Life Sciences Wholly Owned Subsidiary Filament Health Completes Shipment of PEX010 for University of Washington Phase 2a Trial in Cancer-Related Anxiety and Depression
Toronto, Ontario--(Newsfile Corp. - August 25, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX) (OTCQB: TRUFF) ("Rhelion" or the "Company") an Ontario-based organization advancing innovation
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-08-25 7:20 AM EDT | Rhelion Life Sciences Corp.
Charlotte's Web and Edibles.com Team up to Protect Consumer Access and Shape Hemp's Future
Louisville, Colorado--(Newsfile Corp. - August 25, 2026) - Charlotte's Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF), a market leader in hemp wellness, and Edibles.com, a premier retailer and online marketplace, announced a strategic partnership to expand consumer access to trusted hemp wellness products. The partnership also signals a growing alignment i
2026-08-25 7:07 AM EDT | Charlotte's Web Holdings, Inc.
TempraMed Signs Definitive Five-Year Saudi Arabia Distribution Agreement for Private-Label VIVI Cap
Highlights Five-year definitive agreement with approximately US$3.8 million in potential minimum purchase commitments, beginning with a firm 10,000-unit initial purchase order. Agreement covers a private-label version of VIVI Cap™ intended for retail commercialization through the physical pharmacy network of Nahdi Medical Company, Saudi Arabia's largest pharmacy chain. TempraMed believes t
Technology, Biotechnology, Pharmaceuticals, Health
2026-08-25 7:00 AM EDT | TempraMed Technologies Ltd.
Apptly Announces $1,000,000 Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - August 24, 2026) - Apptly Health Technologies Corp. (CSE: APPT) (FSE: 4KL) (the "Company") is pleased to announce that it intends to complete a non-brokered private placement of up to 8,000,000 units of the Company (the "Units"), at a price of $0.125 per Unit, for aggregate gross proceeds of up to $1,000,000 (the "Offering"). The Company reserves the right to increase the size of the Offering in its sole discretion. Th
2026-08-24 8:00 PM EDT | Apptly Health Technologies Corp.
LevelJump Announces Q2 Record Revenue
Toronto, Ontario--(Newsfile Corp. - August 24, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), is pleased to announce its financial results for the second quarter ended June 30, 2026. The Company, through its CTS and ADC operations, had a strong quarter as demand continued increasing for our services. Our current focus remains on organic growth, expansion of services, and maximizing revenue opportunities. Financial and Operationa
Healthcare and Hospitals, Health
2026-08-24 7:30 PM EDT | LevelJump Healthcare Corp.